Home › Prostate Cancer › NCT05241236
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
Office Based MRI/Ultrasound Guided Prostate Cancer Ablation: Outcomes Registry
Who can join
Ages 50 and older · Men
Full eligibility criteria
Inclusion Criteria: * Men between 50 and 65 years of age with a clinical diagnosis of prostate cancer with Low or Intermediate risk prostate cancer, and \<50% positive core rate by prostate lobe * Men older than 65 years of age with clinical diagnosis of prostate cancer \<50% positive core rate by prostate lobe * Absence of extra-capsular extension * Absence of seminal vesicle invasion * Absence of regional or distant metastatic disease * Multiparametric MRI of the prostate performed either before the biopsy or \>10 weeks after prostate biopsy * Treated with Cryotherapy of the prostate * Treatment based on co-registration between MP-MRI and Prostate Ultrasound Exclusion Criteria: * Prior treatment of prostate cancer in the form of surgery. * Performance status greater than 0 based on ECOG criteria * Mental status impairment
About the study
This serves as a registration trial. It aims to record short, intermediate, and long-term outcomes of patients treated with targeted laser ablation of biopsy confirmed prostate cancer. Outcomes will be categorized as: 1- Procedure Related, 2- Perioperative - Adverse Events that may occur within 90 days, 3-Oncologic: Recurrence of cancer in treatment area, de-novo tumors, conversion to radical surgery, radiation or cryoablation, emergence of metastasis, 4- Functional: Sexual and Urinary function following treatment
What is being tested
- Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer (device)
Sponsor: Urological Research Network, LLC · Participants: 5,000 · Started: Nov 15, 2020
Contact the study team
- CIELO D GUERRA, BS · Phone: 305-515-9887
- LUANDA SIANO, PA · Phone: 305-822-7227
Official record on ClinicalTrials.gov — NCT05241236
Locations in the U.S.
| Florida | Urological Research Network, Miami Lakes |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.